Moody Lynn & Lieberson, LLC Dexcom Inc Transaction History

Moody Lynn & Lieberson, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 26, 2021	SELL	$78.0 - $104.5 $50,700 - $67,925	-650 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$95.51 - $112.95 $2,196 - $2,597	-23 Reduced 3.42%	650 $268,000
Q2 2020 Jul 24, 2020	SELL	$62.68 - $105.34 $463,330 - $778,673	-7,392 Reduced 91.66%	673 $273,000
Q1 2020 Apr 30, 2020	BUY	$47.79 - $75.63 $385,426 - $609,955	8,065 New	8,065 $2.17 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.